CD200 limits monopoiesis and monocyte recruitment in atherosclerosis
<strong>Rationale:</strong> Inflammation is a basic component of the pathogenesis of atherosclerosis. CD200 is an immune checkpoint known to control macrophage activation. CD200 recently emerged in the Framingham Heart Study and 2 other cohorts as being potentially relevant in CVD. The r...
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Journal article |
| 语言: | English |
| 出版: |
American Heart Association
2021
|